Thurston Springer Miller Herd & Titak’s Franklin US Mid Cap Multifactor Index ETF FLQM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
17,661
+95
+0.5% +$5.39K 0.37% 73
2026
Q1
$965K Sell
17,566
-1,783
-9% -$102K 0.4% 56
2025
Q4
$1.09M Buy
19,349
+17,715
+1,084% +$994K 0.38% 59
2025
Q3
$92.2K Sell
1,634
-23,274
-93% -$1.3M 0.18% 148
2025
Q2
$1.35M Buy
24,908
+21,879
+722% +$1.15M 0.17% 139
2025
Q1
$161K Buy
3,029
+2,861
+1,703% +$156K 0.03% 365
2024
Q4
$9.12K Buy
+168
New +$9.45K ﹤0.01% 911

Other funds holding FLQM

Thurston Springer Miller Herd & Titak's FLQM Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Franklin US Mid Cap Multifactor Index ETF (FLQM) stake by 0.54% in Q2 2026, buying an estimated $5.39K and bringing the position to 17,661 shares worth $1.02M. The position accounts for 0.37% of the portfolio, ranked #73.

Thurston Springer Miller Herd & Titak first reported a position in FLQM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.35M in Q2 2025. 167 funds tracked by Wall St. Rank hold FLQM as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 17,661 shares of Franklin US Mid Cap Multifactor Index ETF worth $1.02M as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 95 Franklin US Mid Cap Multifactor Index ETF shares in Q2 2026, an estimated $5.39K.
  • Franklin US Mid Cap Multifactor Index ETF made up 0.37% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #73 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Franklin US Mid Cap Multifactor Index ETF in Q4 2024 and has held it in 7 quarters since.
  • Thurston Springer Miller Herd & Titak's Franklin US Mid Cap Multifactor Index ETF position peaked at $1.35M in Q2 2025.
  • 167 funds tracked by Wall St. Rank held Franklin US Mid Cap Multifactor Index ETF as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.